Medical Properties Trust (MPW)
(Delayed Data from NYSE)
$15.64 USD
+0.37 (2.42%)
Updated Jul 1, 2022 04:00 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Income Statements
Fiscal Year end for Medical Properties Trust, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | 12/31/17 | |
---|---|---|---|---|---|
Sales | 1,545 | 1,249 | 854 | 785 | 705 |
Cost Of Goods | 39 | 25 | 24 | 9 | 6 |
Gross Profit | 1,506 | 1,224 | 830 | 775 | 699 |
Selling & Adminstrative & Depr. & Amort Expenses | 834 | 725 | 508 | 485 | 213 |
Income After Depreciation & Amortization | 671 | 500 | 323 | 290 | 486 |
Non-Operating Income | 60 | -36 | 51 | 729 | -15 |
Interest Expense | 0 | 0 | 0 | 0 | 177 |
Pretax Income | 731 | 463 | 374 | 1,019 | 294 |
Income Taxes | 74 | 31 | -3 | 1 | 3 |
Minority Interest | 1 | 1 | 2 | 2 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 657 | 432 | 376 | 1,018 | 291 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income | 656 | 431 | 375 | 1,017 | 290 |
Depreciation Footnote | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | 12/31/17 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,022 | 789 | 488 | 439 | 624 |
Depreciation & Amortization (Cash Flow) | 351 | 289 | 165 | 149 | 139 |
Income After Depreciation & Amortization | 671 | 500 | 323 | 290 | 486 |
Earnings Per Share Data | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | 12/31/17 |
---|---|---|---|---|---|
Average Shares | 590.14 | 530.46 | 428.30 | 366.27 | 350.44 |
Diluted EPS Before Non-Recurring Items | 1.11 | 0.81 | 0.87 | 2.76 | 0.82 |
Diluted Net EPS | 1.11 | 0.81 | 0.87 | 2.76 | 0.82 |
Fiscal Year end for Medical Properties Trust, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/22 | 3/31/22 | 12/31/21 | 9/30/21 | 6/30/21 | |
---|---|---|---|---|---|
Sales | 409.80 | 409.33 | 390.78 | 381.79 | 362.77 |
Cost Of Goods | 8.60 | 7.83 | 7.13 | 18.68 | 5.45 |
Gross Profit | 401.20 | 401.50 | 383.65 | 363.11 | 357.31 |
SG&A, R&D, and Dept/Amort Expenses | 217.93 | 216.51 | 215.87 | 203.22 | 198.69 |
Income After SG&A, R&D, and Dept/Amort Expenses | 183.27 | 184.99 | 167.78 | 159.89 | 158.62 |
Non-Operating Income | 460.05 | 26.66 | 14.21 | 5.11 | 13.62 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 643.33 | 211.65 | 182.00 | 165.00 | 172.24 |
Income Taxes | 11.38 | 4.81 | 10.60 | 50.18 | 8.36 |
Minority Interest | 0.27 | 0.31 | 0.26 | 0.26 | 0.10 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 631.95 | 206.84 | 171.40 | 114.82 | 163.88 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 631.68 | 206.54 | 171.14 | 114.57 | 163.78 |
Earnings Per Share Data | 6/30/22 | 3/31/22 | 12/31/21 | 9/30/21 | 6/30/21 |
---|---|---|---|---|---|
Average Shares | 598.93 | 596.67 | 597.32 | 589.05 | 577.54 |
Diluted EPS Before Non-Recurring Items | 1.05 | 0.34 | 0.29 | 0.19 | 0.27 |
Diluted Net EPS | 1.05 | 0.35 | 0.29 | 0.19 | 0.28 |